Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MSCs vs. iPSCs: Potential in therapeutic applications

2 Nov 2022

Abstract excerpt

Over the past 2 decades, mesenchymal stem cells (MSCs) have attracted a lot of interest as a unique therapeutic approach for a variety of diseases. MSCs are capable of self-renewal and multilineage differentiation capacity, immunomodulatory, and anti-inflammatory properties allowing it to play a role in regenerative medicine. Furthermore, MSCs are low in tumorigenicity and immune privileged, which permits the use...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mesenchymal stem cell research
Share to Pluripotent Stem Cells Research
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36407112
DOI: 10.3389/fcell.2022.1005926

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MSCs vs. iPSCs: Potential in therapeutic applicationsPMID 36407112Read ↗

Advancements and Innovative Strategies in Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cell Therapy: A Comprehensive ReviewSemantic proximity Read ↗

Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future.Semantic proximity Read ↗

Induced pluripotent stem cell-derived mesenchymal stem cells: whether they can become new stars of cell therapySemantic proximity Read ↗

Induced Mesenchymal Stem Cells: An Emerging Source for Regenerative Medicine ApplicationsSemantic proximity Read ↗

Production of Mesenchymal Stem Cells through Stem Cell ReprogrammingSemantic proximity Read ↗

Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectivesSemantic proximity Read ↗

Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative MedicineSemantic proximity Read ↗

Comparative analysis of mesenchymal stem/stromal cells derived from human induced pluripotent stem cells and the cognate umbilical cord mesenchymal stem/stromal cellsSemantic proximity Read ↗

Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34posHematopoietic Stem Cell Propagation and Suppress Inflammatory ReactionSemantic proximity Read ↗

hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicine.Semantic proximity Read ↗

Differentiation of Mesenchymal Stem Cells from Human Induced Pluripotent Stem Cells Results in Downregulation of c-Myc and DNA Replication Pathways with Immunomodulation Toward CD4 and CD8 CellsSemantic proximity Read ↗

Adult Mesenchymal Stem Cells: A Pluripotent Population with Multiple ApplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.